A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx™) in the treatment of elderly patients with metastatic breast cancer
2007 ◽
Vol 61
(1)
◽
pp. 84-89
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 9122-9122
◽
2008 ◽
Vol 8
(3)
◽
pp. 331-342
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. e19740-e19740
◽
2008 ◽
Vol 34
(5)
◽
pp. 391-406
◽
2012 ◽
2008 ◽
Vol 31
(4)
◽
pp. 369-374
◽
2009 ◽
Vol 117
(3)
◽
pp. 591-598
◽